Recommended Antibiotic for Mildly Infected Skin Abrasion with Yellow Dye Allergy
For this patient with a mildly infected skin abrasion and a yellow dye allergy alert (not a true cephalexin allergy), prescribe cephalexin as originally intended—the yellow dye allergy is not a contraindication to cephalosporin use.
Understanding the Yellow Dye Alert
The alert triggered when ordering cephalexin is a non-allergic excipient sensitivity, not a true antibiotic allergy. Yellow dyes (such as tartrazine/FD&C Yellow No. 5) are inactive ingredients in some pharmaceutical formulations that can cause non-immunologic reactions in susceptible individuals, but this has no relationship to the antibiotic's active ingredient or β-lactam structure.
Key distinction: This is fundamentally different from a penicillin or cephalosporin allergy, which involves immunologic reactions to the β-lactam ring or side chains 1.
Primary Recommendation: Cephalexin
Cephalexin remains the appropriate first-line antibiotic for this mild skin infection because:
- First-generation cephalosporins (including cephalexin) are the guideline-recommended treatment for mild skin and soft tissue infections caused by S. aureus and streptococci 2
- The yellow dye is an excipient issue that can be resolved by selecting a cephalexin formulation without yellow dye
- Most generic cephalexin capsules and suspensions are available in dye-free formulations
Practical Solution
- Request the pharmacy to dispense a dye-free cephalexin formulation
- Document in the allergy field that this is an excipient sensitivity, not a drug allergy, to prevent future confusion
- Standard dosing: 500 mg orally four times daily or 250 mg orally four times daily for mild infections 2
Alternative Antibiotics (If Cephalexin Truly Unavailable)
If a dye-free cephalexin formulation cannot be obtained, consider these alternatives for mild infected skin abrasions:
Option 1: Dicloxacillin
- Penicillinase-resistant penicillin, equally effective for methicillin-susceptible S. aureus and streptococci 2
- Dosing: 500 mg orally four times daily
- No cross-reactivity concern with yellow dye sensitivity
Option 2: Amoxicillin-Clavulanate
- Broad-spectrum coverage for S. aureus and streptococci 3
- Dosing: 875 mg/125 mg orally twice daily
- Offers best guarantee of efficacy for uncomplicated superficial skin infections 3
Option 3: Clindamycin
- Alternative for patients with true penicillin allergy 2
- Dosing: 300-450 mg orally three to four times daily
- Effective against both MSSA and MRSA
- Consider if local MRSA prevalence is high
Option 4: Doxycycline or Trimethoprim-Sulfamethoxazole
- Alternatives mentioned in guidelines for penicillin-allergic patients or MRSA coverage 2
- Doxycycline: 100 mg orally twice daily
- TMP-SMX: 1-2 double-strength tablets orally twice daily
Critical Pitfall to Avoid
Do not confuse excipient sensitivities with true drug allergies. Yellow dye sensitivity does not predict or indicate:
- β-lactam allergy
- Cross-reactivity with cephalosporins or penicillins
- Risk of anaphylaxis from cephalexin
The cephalosporin class is contraindicated only in patients with known allergy to the cephalosporin group of antibiotics 1, not to pharmaceutical dyes.
Clinical Context
For this mild infected skin abrasion, the infection likely involves S. aureus and/or β-hemolytic streptococci 2. The IDSA guidelines clearly state that oral penicillinase-resistant penicillins or first-generation cephalosporins are usually effective, as most staphylococcal isolates from these superficial infections are methicillin-susceptible 2.
Topical therapy with mupirocin or retapamulin could also be considered if the infection is very localized, as topical treatment is as effective as oral antimicrobials for impetigo and similar superficial infections 2. However, systemic therapy is preferred for patients with numerous lesions or to decrease transmission 2.